Literature DB >> 30706400

Gene Transfer to Mouse Kidney In Vivo.

C J Rocca1, S Cherqui2.   

Abstract

Genetic nephropathies represent a challenging class of disorders to be treated by gene therapy. This is primarily due to the filtering properties of the kidney itself, which does not allow the vehicle carrying the transgene of interest to remain long enough in the organ to penetrate efficiently into the nephrotic cells. Also, the kidney has a complex anatomical structure composed of different cell types compartmentalized within isolated anatomic structures that limit their access. Here, we describe a simple surgical procedure to deliver recombinant adeno-associated virus (rAAV) to the whole kidney based on the hydraulic force of the retrograde renal vein injection. In its clinical form, this procedure would correspond to a renal venography where a catheter is threaded retrograde from the femoral vein under fluoroscopic guidance.

Entities:  

Keywords:  Gene therapy; Genetic; Kidney; Mouse; Nephropathies; Recombinant adeno-associated virus; Renal vein injection

Mesh:

Year:  2019        PMID: 30706400      PMCID: PMC8020872          DOI: 10.1007/978-1-4939-9065-8_14

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  12 in total

1.  Gene delivery in renal tubular epithelial cells using recombinant adeno-associated viral vectors.

Authors:  Sifeng Chen; Anupam Agarwal; Olena Y Glushakova; Marda S Jorgensen; Shashikumar K Salgar; Amy Poirier; Terence R Flotte; Byron P Croker; Kirsten M Madsen; Mark A Atkinson; William W Hauswirth; Kenneth I Berns; C Craig Tisher
Journal:  J Am Soc Nephrol       Date:  2003-04       Impact factor: 10.121

2.  Short-term efficiency and safety of gene delivery into canine kidneys.

Authors:  V Chetboul; B Klonjkowski; H P Lefebvre; D Desvaux; V Laroute; D Rosenberg; C Maurey; F Crespeau; M Adam; S Adnot; M Eloit; J L Pouchelon
Journal:  Nephrol Dial Transplant       Date:  2001-03       Impact factor: 5.992

Review 3.  Rare inherited kidney diseases: challenges, opportunities, and perspectives.

Authors:  Olivier Devuyst; Nine V A M Knoers; Giuseppe Remuzzi; Franz Schaefer
Journal:  Lancet       Date:  2014-05-24       Impact factor: 79.321

Review 4.  Living-donor kidney transplantation: a review of the current practices for the live donor.

Authors:  Connie L Davis; Francis L Delmonico
Journal:  J Am Soc Nephrol       Date:  2005-06-01       Impact factor: 10.121

5.  Kidney-targeted naked DNA transfer by retrograde renal vein injection in rats.

Authors:  Hiroki Maruyama; Noboru Higuchi; Yuji Nishikawa; Hiroyuki Hirahara; Noriaki Iino; Shigemi Kameda; Hiroshi Kawachi; Eishin Yaoita; Fumitake Gejyo; Jun-Ichi Miyazaki
Journal:  Hum Gene Ther       Date:  2002-02-10       Impact factor: 5.695

6.  Kidney transplantation in the United States.

Authors:  J Michael Cecka
Journal:  Clin Transpl       Date:  2008

7.  Comparison of the transduction efficiency of tyrosine-mutant adeno-associated virus serotype vectors in kidney.

Authors:  Yan F Qi; Qiu H Li; Vinayak Shenoy; Michael Zingler; Joo Y Jun; Amrisha Verma; Michael J Katovich; Mohan K Raizada
Journal:  Clin Exp Pharmacol Physiol       Date:  2013-01       Impact factor: 2.557

Review 8.  Trends in kidney transplantation over the past decade.

Authors:  Greg Knoll
Journal:  Drugs       Date:  2008       Impact factor: 9.546

9.  Successful gene transfer using adeno-associated virus vectors into the kidney: comparison among adeno-associated virus serotype 1-5 vectors in vitro and in vivo.

Authors:  Shin-ichi Takeda; Masafumi Takahashi; Hiroaki Mizukami; Eiji Kobayashi; Koichi Takeuchi; Yoji Hakamata; Takashi Kaneko; Hisashi Yamamoto; Chiharu Ito; Keiya Ozawa; Kenichi Ishibashi; Toshiyuki Matsuzaki; Kuniaki Takata; Yasushi Asano; Eiji Kusano
Journal:  Nephron Exp Nephrol       Date:  2004

10.  rAAV9 combined with renal vein injection is optimal for kidney-targeted gene delivery: conclusion of a comparative study.

Authors:  C J Rocca; S N Ur; F Harrison; S Cherqui
Journal:  Gene Ther       Date:  2014-05-01       Impact factor: 5.250

View more
  3 in total

Review 1.  Improving Molecular Therapy in the Kidney.

Authors:  Jeffrey D Rubin; Michael A Barry
Journal:  Mol Diagn Ther       Date:  2020-08       Impact factor: 4.074

2.  Comparison of Gene Delivery to the Kidney by Adenovirus, Adeno-Associated Virus, and Lentiviral Vectors After Intravenous and Direct Kidney Injections.

Authors:  Jeffrey D Rubin; Tien V Nguyen; Kari L Allen; Katayoun Ayasoufi; Michael A Barry
Journal:  Hum Gene Ther       Date:  2019-12-03       Impact factor: 5.695

Review 3.  Oligonucleotide-Based Therapies for Renal Diseases.

Authors:  Fernando Cartón-García; Cassondra Jeanette Saande; Daniel Meraviglia-Crivelli; Rafael Aldabe; Fernando Pastor
Journal:  Biomedicines       Date:  2021-03-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.